Theriva Biologics, Inc. Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 05/05/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 05/05/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 11/08/2025 | Mar 2024Filed 14/05/2025 |
|---|---|---|---|---|---|---|---|---|
| — | $0.3 | — | — | — | — | — | — | |
| −$3.2 | −$2 | −$4.4 | −$13 | −$4.3 | −$7.7 | −$8.3 | −$5.2 | |
| −$0.07 | −$0.05 | −$0.45 | −$1.93 | −$1.55 | −$6.81 | −$10.72 | −$7.53 | |
| 46 | 41 | 9.7 | 6.8 | 2.8 | 1.1 | — | — |
Trend